GoBroad Healthcare Group is pleased to announce that Dr. Jing Pan, a pediatric hematology and immunotherapy specialist at GoBroad Healthcare Group, has been appointed to the Founding Editorial Advisory Board of Pediatric, Adolescent & Young Adult Cancer (PAYAC), a newly launched peer-reviewed journal published by the American Cancer Society (ACS).

Launched in 2026, PAYAC is an international, open-access journal dedicated to advancing research and improving outcomes for children, adolescents, and young adults with cancer. As the newest member of the ACS family of journals—which includes internationally renowned publications such as CA: A Cancer Journal for Clinicians and Cancer—PAYAC serves as a global platform for high-quality research and clinical innovation across the full spectrum of pediatric and adolescent and young adult (AYA) oncology.

The journal is led by its inaugural Editor-in-Chief, Prof. Nirali N. Shah of the National Cancer Institute (NCI), a globally recognized leader in targeted immunotherapies, including CAR-T cell therapy for children and young adults with high-risk hematologic malignancies. The editorial leadership team also includes internationally distinguished experts from Memorial Sloan Kettering Cancer Center and Moffitt Cancer Center.

Dr. Pan's appointment to the Founding Editorial Advisory Board reflects her internationally recognized expertise in pediatric hematology, immunotherapy, and translational medicine. As one of the leading pediatric hematology and immunotherapy specialists at GoBroad Healthcare Group, she has made significant contributions to the development of innovative cellular immunotherapies and the treatment of children with hematologic malignancies and other serious blood disorders. Through this role, Dr. Pan will contribute to shaping the journal's academic development and promoting international collaboration and knowledge exchange in pediatric and AYA oncology.

GoBroad Healthcare Group remains committed to advancing clinical innovation, translational research, and international academic collaboration in hematology and oncology. Dr. Pan's appointment further demonstrates the growing global recognition of the expertise and academic leadership of GoBroad's physicians.

PAYAC welcomes submissions covering basic and translational research, clinical trials, novel therapies, cancer prevention and early detection, survivorship, psychosocial care, artificial intelligence, bioinformatics, and other emerging areas in pediatric and AYA oncology.

The journal is now accepting manuscript submissions.

Journal homepage:

https://acsjournals.onlinelibrary.wiley.com/journal/30683513

Manuscript submissions:

https://authors.wiley.com/journal/PAY2